C

Carasent ASA
OSE:CARA

Watchlist Manager
Carasent ASA
OSE:CARA
Watchlist
Price: 20.5 NOK 2.5% Market Closed
Market Cap: 1.5B NOK
Have any thoughts about
Carasent ASA?
Write Note

Intrinsic Value

The intrinsic value of one CARA stock under the Base Case scenario is 19.95 NOK. Compared to the current market price of 20.5 NOK, Carasent ASA is Overvalued by 3%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

CARA Intrinsic Value
19.95 NOK
Overvaluation 3%
Intrinsic Value
Price
C
Worst Case
Base Case
Best Case

Valuation Backtest
Carasent ASA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for CARA cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about CARA?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Investment Journal
AI Assistant
AI Assistant
Ask me anything about Carasent ASA

Provide an overview of the primary business activities
of Carasent ASA.

What unique competitive advantages
does Carasent ASA hold over its rivals?

What risks and challenges
does Carasent ASA face in the near future?

Summarize the latest earnings call
of Carasent ASA.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Carasent ASA.

Provide P/S
for Carasent ASA.

Provide P/E
for Carasent ASA.

Provide P/OCF
for Carasent ASA.

Provide P/FCFE
for Carasent ASA.

Provide P/B
for Carasent ASA.

Provide EV/S
for Carasent ASA.

Provide EV/GP
for Carasent ASA.

Provide EV/EBITDA
for Carasent ASA.

Provide EV/EBIT
for Carasent ASA.

Provide EV/OCF
for Carasent ASA.

Provide EV/FCFF
for Carasent ASA.

Provide EV/IC
for Carasent ASA.

Show me price targets
for Carasent ASA made by professional analysts.

What are the Revenue projections
for Carasent ASA?

How accurate were the past Revenue estimates
for Carasent ASA?

What are the Net Income projections
for Carasent ASA?

How accurate were the past Net Income estimates
for Carasent ASA?

What are the EPS projections
for Carasent ASA?

How accurate were the past EPS estimates
for Carasent ASA?

What are the EBIT projections
for Carasent ASA?

How accurate were the past EBIT estimates
for Carasent ASA?

Compare the revenue forecasts
for Carasent ASA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Carasent ASA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Carasent ASA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Carasent ASA compared to its peers.

Compare the P/E ratios
of Carasent ASA against its peers.

Discuss the investment returns and shareholder value creation
comparing Carasent ASA with its peers.

Analyze the financial leverage
of Carasent ASA compared to its main competitors.

Show all profitability ratios
for Carasent ASA.

Provide ROE
for Carasent ASA.

Provide ROA
for Carasent ASA.

Provide ROIC
for Carasent ASA.

Provide ROCE
for Carasent ASA.

Provide Gross Margin
for Carasent ASA.

Provide Operating Margin
for Carasent ASA.

Provide Net Margin
for Carasent ASA.

Provide FCF Margin
for Carasent ASA.

Show all solvency ratios
for Carasent ASA.

Provide D/E Ratio
for Carasent ASA.

Provide D/A Ratio
for Carasent ASA.

Provide Interest Coverage Ratio
for Carasent ASA.

Provide Altman Z-Score Ratio
for Carasent ASA.

Provide Quick Ratio
for Carasent ASA.

Provide Current Ratio
for Carasent ASA.

Provide Cash Ratio
for Carasent ASA.

What is the historical Revenue growth
over the last 5 years for Carasent ASA?

What is the historical Net Income growth
over the last 5 years for Carasent ASA?

What is the current Free Cash Flow
of Carasent ASA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Carasent ASA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Carasent ASA

Current Assets 439.5m
Cash & Short-Term Investments 375.7m
Receivables 57.1m
Other Current Assets 6.7m
Non-Current Assets 651.4m
PP&E 46.3m
Intangibles 605m
Other Non-Current Assets -1k
Current Liabilities 111.4m
Accounts Payable 17m
Accrued Liabilities 28.9m
Other Current Liabilities 65.5m
Non-Current Liabilities 44.4m
Long-Term Debt 34m
Other Non-Current Liabilities 10.4m
Efficiency

Earnings Waterfall
Carasent ASA

Revenue
254m NOK
Cost of Revenue
-43.8m NOK
Gross Profit
210.2m NOK
Operating Expenses
-242.6m NOK
Operating Income
-32.4m NOK
Other Expenses
22m NOK
Net Income
-10.4m NOK

Free Cash Flow Analysis
Carasent ASA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

CARA Profitability Score
Profitability Due Diligence

Carasent ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Positive Revenue Growth Forecast
Positive 1-Year Revenue Growth
42/100
Profitability
Score

Carasent ASA's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

CARA Solvency Score
Solvency Due Diligence

Carasent ASA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Long-Term Solvency
Negative Net Debt
Short-Term Solvency
75/100
Solvency
Score

Carasent ASA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

CARA Price Targets Summary
Carasent ASA

Wall Street analysts forecast CARA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CARA is 27.29 NOK with a low forecast of 26.77 NOK and a high forecast of 28.35 NOK.

Lowest
Price Target
26.77 NOK
31% Upside
Average
Price Target
27.29 NOK
33% Upside
Highest
Price Target
28.35 NOK
38% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for CARA?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for CARA is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Carasent ASA

Country

Norway

Industry

Health Care

Market Cap

1.5B NOK

Dividend Yield

0%

Description

Carasent ASA is an investment management company, which in the development of entrepreneurial and e-health solutions. The company is headquartered in Oslo, Oslo. The company went IPO on 2002-04-08. The company operates through its subsidiary Evimeria EMR AB, which offers digital eHealth services primarily at specialist care, primary care and paramedics. The firm provides Webdoc, a Web-based care management system for health professionals that reduces the risk of resource-intensive routines. The system is customizable and also offers integration solutions. The firm is active in the Nordic region.

Contact

OSLO
Oslo
Ovre Slottsgate 2B
+46733550935.0
carasent.com

IPO

2002-04-08

Employees

-

Officers

Chief Financial Officer
Mr. Svein Martin Bjornstad
Chief Executive Officer
Mr. Daniel Ohman
Chief Technical Officer
Johan Eltes
Legal Counsel
Advocate Jon Schultz
Chief Compliance Officer
Stefan Jernberg
Vice President of Sales & Business Development
Mr. Chris Damvakaris
Show More
Chief Marketing Officer
Cornelia Broqvist
People and Culture Manager
Anna Holmen Larsson
Head of Strategy
Vilma Jonson
Show Less

See Also

Discover More
What is the Intrinsic Value of one CARA stock?

The intrinsic value of one CARA stock under the Base Case scenario is 19.95 NOK.

Is CARA stock undervalued or overvalued?

Compared to the current market price of 20.5 NOK, Carasent ASA is Overvalued by 3%.

Back to Top